1007877-76-0

Basic information

• Product Name: (R)-tert-butyl 2-(methoxycarbonylamino)-2-phenylacetate
• Synonyms: (R)-tert-butyl 2-(methoxycarbonylamino)-2-phenylacetate
• CAS NO: 1007877-76-0
• Molecular Weight: 265.309
• Mol File: 1007877-76-0.mol
• Article Data: 17

Chemical Properties

• CAS DataBase Reference: (R)-tert-butyl 2-(methoxycarbonylamino)-2-phenylacetate(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-tert-butyl 2-(methoxycarbonylamino)-2-phenylacetate(1007877-76-0)
• EPA Substance Registry System: (R)-tert-butyl 2-(methoxycarbonylamino)-2-phenylacetate(1007877-76-0)

Safety Data

• Hazardous Substances Data: 1007877-76-0(Hazardous Substances Data)

Upstream product

• 79-22-1 methyl chloroformate 
• 96-34-4 methyl chloroacetate 
• 53934-78-4 (R)-phenylglycine tert-butyl ester 

Downstream Products

• 50890-96-5 (2R)-2-[(methoxycarbonyl)amino]-2-phenylacetic acid 
• 1085706-55-3 dimethyl-(1R,1'R)-2,2'-((2S,2'S)-2,2'-(5,5'-(biphenyl-4,4'-diyl)bis(1H-pyrazole-5,3-diyl))bis(pyrrolidine-2,1-diyl))bis(2-oxo-1-phenylethane-2,1-diyl)dicarbamate 
• 1007882-36-1 methyl ((1R)-2-((2S)-2-(5-(4'-(2-((1S)-1-(((2R)-2-((methoxy-carbonyl)amino)-2-phenyl-acetyl)(methyl)amino)ethyl)-1H-imidazol-5-yl)-4-biphenylyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)-2-oxo-1-phenyl-ethyl)carbamate 
• 1007882-33-8 dimethyl (4,4'-biphenyldiylbis(1H-imidazole-5,2-diyl(1S)-1,1-ethanediyl(methylimino)((1R)-2-oxo-1-phenyl-2,1-ethanediyl)))biscarbamate 

Relevant articles and documents

HEPATITIS C VIRUS INHIBITORS

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

HEPATITIS C VIRUS INHIBITORS

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

HEPATITIS C VIRUS INHIBITORS

The present disclosure relates to methods for making compounds useful in the treatment of Hepatitis C virus (HCV) infection.